Insiders Eli Lilly and Company Wiener Boerse

Equities

LLYC

US5324571083

End-of-day quote Wiener Boerse Other stock markets 18:00:00 2024-05-28 EDT			5-day change	1st Jan Change
751.1 ^EUR	+1.39%		+0.82%	+42.25%

02:00pm	Eli Lilly and Company Announces Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting	CI
05-30	Danish Government Implements Stricter Subsidy Rules for Diabetes Drugs	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Eli Lilly Ethics/Compliance Chief Alonzo Weems to Retire	05-15	DJ
Eli Lilly: Alonzo Weems to retire at the end of the year	05-15	CF
Eli Lilly and Company Announces Retirement of Alonzo Weems, Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer, Effective December 31, 2024	05-15	CI
Novo Nordisk CEO: Demand for Wegovy outstrips supply	05-02	MT
David Ricks, CEO of Eli Lilly: A market of over a billion people	03-12	MT
Eli Lilly Insider Sold Shares Worth $565,200, According to a Recent SEC Filing	03-11	MT
Global markets live: Darktrace, Merck, Meta, Apple, Eli Lilly...	03-07
WeightWatchers shares drop as Oprah Winfrey decides to exit board	02-29	RE
Philip Johnson to Retire as Eli Lilly and Company's Treasurer	02-09	CI
Eli Lilly: departure of Vice President Quality	01-26	CF
Eli Lilly Executive VP of Global Quality Johna Norton to Retire	01-25	DJ
Johna Norton to Retire as Lilly Executive Vice President of Global Quality	01-25	CI
Arecor inks Eli Lilly deal; RBG appoints McNair CFO	11-29	AN
A new ETF dedicated to anti-obesity drugs (Ozempic, Mounjaro, Wegovy)!	11-27	MT
Eli Lilly & Insider Sold Shares Worth $382,637, According to a Recent SEC Filing	11-06	MT
Eli Lilly Appoints CordenPharma to Manufacture Active Ingredient for Diabetes Drug	23-10-19	MT
Eli Lilly and Company Announces Executive Changes	23-10-04	CI
Eli Lilly Appoints New Chief Medical Officer, Global Chief Customer Officer	23-10-04	MT
Eli Lilly's head of diabetes and obesity unit to retire	23-10-04	RE
Eli Lilly Insider Sold Shares Worth $678,445, According to a Recent SEC Filing	23-09-13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm